Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex

Neuropharmacology

Volumn 45, Issue 8, 2003, Pages 1050-1056

  Ago, Yukio ^a   Koyama, Yutaka ^a   Baba, Akemichi ^a   Matsuda, Toshio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Microdialysis; Mouse; Postsynaptic; Presynaptic; Serotonin receptors; WAY100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DOPAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OSEMOZOTAN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; SEROTONIN RECEPTOR AFFECTING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIALYSIS; DOPAMINE RELEASE; DRUG MEGADOSE; FRONTAL CORTEX; MALE; MECHANICAL PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN RELEASE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FRONTAL LOBE; METABOLISM; SECRETION;

ANIMALS; DOPAMINE; DOPAMINE AGENTS; FRONTAL LOBE; MALE; MICE; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGENTS;

EID: 0242712188     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00304-6     Document Type: Article

References (47)

1. Abe M., Tabata R., Saito K., Matsuda T., Baba A., Egawa M. Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1, 3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models. Journal of Pharmacology and Experimental Therapeutics. 278:1996;898-905.
2. 1A receptor-mediated dopamine release in vivo in the frontal cortex of mice. Journal of Neurochemistry. 83:2002;353-359.
3. 1A antagonists. Trends in Neurosciences. 19:1996;378-383.
4. 1A receptors in rat brain. Japanese Journal of Pharmacology. 74:1997;69-75.
5. Assié M.-B., Koek W. Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. British Journal of Pharmacology. 119:1996;845-850.
6. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
7. 1A syndrome. Pharmacology, Biochemistry and Behavior. 57:1997;897-908.
8. Blier P., Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. Journal of Clinical Psychopharmacology. 15:1995;217-222.
9. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends in Pharmacological Sciences. 15:1994;220-226.
10. 1A receptors control 5-HT release in the rat medial prefrontal cortex. Neuroreport. 10:1999;1441-1445.
11. 1A receptors in human and rat brain. Journal of Neurochemistry. 75:2000;755-762.
12. A, and glutamate receptors. Journal of Neuroscience. 21:2001;9917-9929.
13. Chen N.H., Reith M.E.A. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systematically with (±)-8-hydroxy-2-(di-n-propylamino)tetralin. Journal of Neurochemistry. 64:1995;1585-1597.
14. Corradetti R., Le Poul E., Laaris N., Hamon M., Lanfumey L. Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)- N-(2-pyridinyl) cyclohexane carboxamide (WAY100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro. Journal of Pharmacology and Experimental Therapeutics. 278:1996;679-688.
15. 1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex. European Journal of Pharmacology. 345:1998;41-46.
16. 1A receptor antagonism. Neuropharmacology. 38:1999;1153-1163.
17. Dulawa S.C., Geyer M.A. Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology. 39:2000;2170-2179.
18. 1A receptor modulation of anxiety in two ethological animal tests. Journal of Neuroscience. 16:1996;4810-4815.
19. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, Inc, San Diego.
20. Gobert A., Rivet J.-M., Audinot V., Newman-Tancredi A., Cistarelli L., Millan M.J. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience. 84:1998;413-429.
21. 2-adernergic receptors underlie its actions. Neuroscience. 93:1999;1251-1262.
22. 1A receptor-induced inhibition of 5-HT neuronal activity in the rat. British Journal of Pharmacology. 126:1999;1741-1750.
23. 1A receptors on central noradrenergic activity: microdialysis studies using (±)-MDL 73005EF and its enantiomers. Neuropharmacology. 38:1999;299-306.
24. 35S]-GTPγS binding as measured by quantitative autoradiography following chronic agonist administration. British Journal of Pharmacology. 132:2001;605-611.
25. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. Journal of Neurochemistry. 60:1993;776-779.
26. Hjorth S. (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. European Journal of Pharmacology. 303:1996;183-186.
27. 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedebergs Archives of Pharmacology. 338:1988;463-471.
28. Lucki I. Behavioral studies of serotonin receptor agonists as antidepressant drugs. Journal of Clinical Psychiatry. 52:(Suppl.):1991;24-31.
29. 1A receptor control of dorsal raphe 5-HT neurones. Neuropharmacology. 41:2001;72-78.
30. 11C]WAY100635 and positron emission tomography in humans. Neuropsychopharmacology. 24:2001;209-229.
31. 1A receptor activation in mice. European Journal of Pharmacology. 280:1995a;235-238.
32. 1A receptors. Japanese Journal of Pharmacology. 69:1995b;357-366.
33. 1A agonists. Molecular Pharmacology. 37:1990;231-237.
34. 2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. Journal of Pharmacology and Experimental Therapeutics. 282:1997;132-147.
35. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Research. 346:1985;205-230.
36. Plassat J.L., Amlaiky N., Hen R. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Molecular Pharmacology. 44:1993;229-236.
37. 1A receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain. Synapse. 34:1999;68-76.
38. 1a receptor agonists block prepulse inhibition of the acoustic startle reflex. Journal of Pharmacology and Experimental Therapeutics. 263:1992;486-493.
39. Romero L., Celada P., Artigas F. Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/Go proteins in dorsal raphe nucleus. European Journal of Pharmacology. 265:1994;103-106.
40. 1A receptors: In vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology. 15:1996a;349-360.
41. 1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neuroscience Letters. 219:1996;123-126.
42. 1A receptor activation increases in vivo dopamine release in rat prefrontal cortex. British Journal of Pharmacology. 129:2000;1028-1034.
43. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. British Journal of Pharmacology. 96:1989;283-290.
44. Sipes T.A., Geyer M.A. 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology. 117:1995;41-48.
45. 1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats. Journal of Pharmacology and Experimental Therapeutics. 288:1999;843-848.
46. 1A receptor-related anxiolytics. Trends in Pharmacological Sciences. 8:1987;432-437.
47. 7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons. Brain Research. 755:1997;246-254.